Home : Unsafe Drugs : Seroquel : News Articles
Seroquel - News Articles
-
Jul 29, 2008
Wall Street Journal -
By JEANNE WHALEN Sanofi-Aventis SA said a court in Germany allowed a generic version of the company's blockbuster drug Plavix onto the market there, ... -
Jul 29, 2008
Reuters -
By Ben Hirschler LONDON (Reuters) - French drugmaker Sanofi-Aventis (SASY.PA: Quote, Profile, Research) and its US partner Bristol-Myers Squibb Co (BMY. N) Quote Profile ... -
Jul 30, 2008
Wall Street Journal Blogs, NY -
1. Abbott’s Depakote, approved for epilepsy, bipolar disorder and migraines, is now generic in the US, the FDA said. A bunch of generics manufacturers — including Teva, Dr. Reddy’s and Novartis’s Sandoz — will sell the drug, the agency said. Depakote was ... -
Jul 31, 2008
Bloomberg -
By Trista Kelley July 31 (Bloomberg) -- Sanofi-Aventis SA, France's largest drugmaker, reported second-quarter earnings that missed analyst estimates, ... -
Friday, August 01, 2008
The News Journal, DE -
The antipsychotic drug Seroquel saw a sales gain of 15 percent in the quarter, and asthma treatment Symbicort rose by 25 percent. Sales of the breast cancer ... -
Friday, August 01, 2008
RedOrbit, TX -
Handa Pharmaceuticals has confirmed that its abbreviated new drug application for quetiapine fumarate extended-release tablets, the generic version of AstraZeneca's Seroquel XR, has been accepted for filing by the FDA. ... -
Jun 30, 2008
SunHerald.com, MS -
By Johnson & Johnson Patriot is a subsidiary of McNeil-PPC. Both companies are a part of the Johnson & Johnson family of companies. Janssen also announced that it will continue to make available branded RISPERDAL, which was ... -
Jun 30, 2008
WELT ONLINE, Germany -
Teva Pharmaceutical Industries Ltd. (NASDAQ:TEVA) announced today that the US Food and Drug Administration has granted final approval for the Company's ... -
Jun 30, 2008
The Canadian Press, NEW YORK -
NEW YORK — Johnson & Johnson's blockbuster anti-psychotic drug Risperdal will face generic competition, as Teva Pharmaceutical Industries Ltd. on Monday became the first company to receive approval for a generic version. Israel-based Teva received U.S. Food and Drug ... -
Jun 29, 2008
Globes, Israel -
UBS Securities has raised its earnings per share forecast for Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) on expectations that it will launch generic Risperdal today. UBS analyst Ricky Goldwasser predicts an extra $0.10 earnings per share in 2008, assuming that ...
-
Jun 30, 2008
Trading Markets (press release), CA -
SAN FRANCISCO, Jul 01, 2008 (Thomson Financial via COMTEX) -- TEVA | Quote | Chart | News | PowerRating -- Teva Pharmaceutical Industries Ltd. said Monday ... -
Jun 30, 2008
FDA.gov -
The US Food and Drug Administration today approved the first generic versions of Risperdal (risperidone) tablets. Risperdal is an antipsychotic drug used for the treatment of schizophrenia, bipolar disorder, and other psychiatric conditions. "This generic drug ... -
Jun 30, 2008
RTT News, NY -
(RTTNews) - Teva Pharmaceutical Industries Ltd. (TEVA: News, Chart, Quote ) said Monday that it received final approval for the its Abbreviated New Drug Application or ANDA to market its generic version of Janssen's antipsychotic agent Risperdal tablets, 0.25 mg, 0.5 mg, 1 ... -
Jun 30, 2008
Earthtimes (press release), UK -
Patriot is a subsidiary of McNeil-PPC. Both companies are a part of the Johnson & Johnson family of companies. Janssen also announced that it will continue to make available branded RISPERDAL, which was first approved by the FDA in 1993. RISPERDAL (risperidone) is indicated ... -
Monday, June 30, 2008
Wilkes Barre Times-Leader, PA -
WASHINGTON — The Food and Drug Administration warned doctors last month that prescribing a certain group of psychiatric drugs to seniors suffering from dementia ... -
Tuesday, July 01, 2008
Trading Markets (press release), CA -
Jul 01, 2008 (Datamonitor via COMTEX) -- TEVA | Quote | Chart | News | PowerRating -- Teva Pharmaceutical Industries has announced that the FDA has granted final approval for the company's abbreviated new drug application to market its generic version of Janssen's antipsychotic agent Risperdal ... -
Tuesday, July 01, 2008
FiercePharma, DC -
By Tracy Staton It's a watershed moment: Risperdal has gone generic. The Johnson & Johnson antipsychotic med now has copycat competition from Teva Pharmaceutical, which got the final FDA go-ahead yesterday. As soon as the agency gave its OK, Teva started shipping. ... -
Tuesday, July 01, 2008
Globes, Israel -
Employees at the troubled Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) subsidiary, Teva Tech, staged a three-hour walkout at the company's ... -
Tuesday, July 01, 2008
United Press International -
WASHINGTON, July 1 (UPI) -- The US Food and Drug Administration says it's approved the first generic versions of Risperdal tablets for certain psychiatric disorders. The FDA said Risperdal (risperidone) is an anti-psychotic drug used for the treatment of schizophrenia, bipolar ... -
Tuesday, July 01, 2008
Trading Markets (press release), CA -
Jul 01, 2008 (Globes - McClatchy-Tribune Information Services via COMTEX) -- TEVA | Quote | Chart | News | PowerRating -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA | Quote | Chart | ...
Pages: Previous 1 2 3 4 5 6 7 8 9 10 11 ... Next





